VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $12,188,000 | -30.9% | 119,900 | +55.3% | 0.31% | -29.8% |
| Q3 2015 | $17,638,000 | +2.8% | 77,200 | 0.0% | 0.45% | -0.2% |
| Q2 2015 | $17,150,000 | -5.8% | 77,200 | -15.8% | 0.45% | +1.6% |
| Q1 2015 | $18,213,000 | +11.7% | 91,700 | -26.2% | 0.44% | +10.0% |
| Q4 2014 | $16,308,000 | +44.7% | 124,300 | +44.7% | 0.40% | +65.7% |
| Q3 2014 | $11,270,000 | +4.0% | 85,900 | 0.0% | 0.24% | +7.6% |
| Q2 2014 | $10,834,000 | +103.9% | 85,900 | +113.2% | 0.22% | +95.7% |
| Q1 2014 | $5,313,000 | – | 40,300 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |